Walgreens offloads stake in infusion company for $330M

Walgreens jettisoned its remaining stake in infusion company Option Care Health for $330 million as it concentrates on its pharmacy and primary care businesses.

Advertisement

The company sold 10.8 million shares of common stock of Option on June 8. Walgreens has been focusing on retail healthcare with its majority stake in primary care chain VillageMD.

Walgreens said it intends to use the proceeds to pay down debt, fund its strategic priorities and further its “transformation to a consumer-centric healthcare company.” The company previously unloaded 15.5 million shares of Option in March.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Disruptors

  • OpenAI signed its first international hospital partnership with Ramat Gan, Israel-based Sheba Medical Center. The deal, according to a July…

  • Microsoft is continuing to hire for health tech roles including a forward deployed AI engineer position tied to its healthcare…

  • Amazon is hiring software and applied-science leaders, AI engineers and a healthcare cybersecurity specialist — the kinds of roles hospital…

Advertisement

Comments are closed.